Nephrosis: Clinical Trials

17 trials for Nephrosis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

17 completed. 17 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 417Completed 17

Follow Nephrosis: new trials by email Literature Review of Nephrosis trials Research Report on Nephrosis

Trials (filtered) newest first · largest first

All 17 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Atorvastatin Therapy in the Treatment of Dyslipidemia in Children With Steroid Sensitive Nephrotic Syndrome
Atorvastatin - Dyslipidaemia
Phase 4CompletedNational Institute of Kidney Disease and Urology (NIKDU)1002024-01-272026-03-27
Clinical Value of Adding Dapagliflozin in Patients With Nephrotic Syndrome
Dapagliflozin 10mg Tab - Nephrotic Syndrome, Sodium-Glucose Transporter 2 Inhibitors
Phase 4CompletedAin Shams University602022-08-012023-09-07
Study of Tacrolimus vs Mycophenolate Mofetil in Pediatric Patients With Nephrotic Syndrome
Tacrolimus, Mycophenolate Mofetil - Nephrotic Syndrome in Children
Phase 4CompletedThe Children's Hospital of Zhejiang University School of Medicine2702019-11-122023-10-17
Active Vitamin D And Reduced Dose Prednisolone for Treatment in Minimal Change Nephropathy
Prednisolone, Alfacalcidol - Minimal Change Disease, Nephrotic Syndrome
Phase 4CompletedUniversity of Aarhus712018-05-012025-01-24
Role of Acetazolamide and Hydrochlorothiazide Followed by Furosemide in Treating Nephrotic Edema
Acetazolamide and Hydrochlorothiazide Followed by Furosemide, Furosemide and Hydrochlorothiazide Followed by Furosemide - Nephrotic Syndrome, Edema
Phase 4CompletedShiraz University of Medical Sciences202015-04-012016-02-23
Efficacy of Usual Vitamin D Supplementation and Its Impact on Children and Adolescents Calciuria.
Cholecalciferol vial (100 000 UI) - Chronic Kidney Disease, Renal Transplantation
Phase 4CompletedHospices Civils de Lyon432014-09-012025-09-04
Mycophenolate Mofetil in Pediatric Steroid Dependent Nephrotic Syndrome
Mycophenolate mofetil - Nephrotic Syndrome
Phase 4CompletedSeoul National University Hospital342013-09-012017-07-06
A Study to Evaluate the Effect of Tacrolimus and Corticosteroid Combination Therapy in Patients With Minimal Change Nephrotic Syndrome
Tacrolimus, Prednisolone - MCNS, Minimal Change Nephrotic Syndrome (MCNS)
Phase 4CompletedAstellas Pharma Korea, Inc.1442012-07-162024-10-31
Pharmacokinetics of Tacrolimus in Children
Tacrolimus - Nephrotic Syndrome
Phase 4CompletedShandong University282012-01-012017-11-20
Acthar for Treatment of Proteinuria in Membranous Nephropathy Patients
Repository Corticotropin Injection, Placebo - Proteinuria, Idiopathic Membranous Nephropathy
Phase 4CompletedMallinckrodt602011-08-012019-11-20
Myfortic® for Minimal Change Nephrotic Syndrome (MCNS): a Randomized Study
Myfortic plus low-dose steroid, Prednisolone - Nephrosis, Lipoid
Phase 4CompletedThe University of Hong Kong202010-09-012018-06-01
Therapeutic Effect of Tacrolimus on Primary Nephrotic Syndrome in Children
Tacrolimus - Nephrotic Syndrome
Phase 4CompletedSeoul National University Hospital772010-07-012019-02-07
Tacrolimus Versus Prednisolone for the Treatment of Minimal Change Disease
tacrolimus, prednisolone - Minimal Change Disease
Phase 4CompletedImperial College Healthcare NHS Trust522009-12-012021-05-04
Prospective Study Evaluating the Effect of Repository Corticotropin in the Treatment of Various Nephrotic Syndromes
Repository corticotrophin - Nephrotic Syndromes
Phase 4CompletedArizona Kidney Disease and Hypertension Center182009-12-012011-07-14
Treatment of Resistant Nephrotic Syndrome With ACTH Gel (ACTHAR)
ACTHAR gel - Treatment Resistant Nephrotic Syndrome
Phase 4CompletedColumbia University152009-12-012014-04-24
Adrenocorticotropic Hormone (ACTH) Treatment of Nephrotic Range Proteinuria in Diabetic Nephropathy (NRDN)
ACTH - Diabetic Nephropathy, Nephrotic Syndrome
Phase 4CompletedSoutheast Renal Research Institute152009-05-012013-05-31
HSP-glomerulonephritis Trial: MP vs CyA
Methylprednisolone pulses plus prednisone versus Cyclosporine A - Purpura, Schoenlein-Henoch
Phase 4CompletedOulu University Hospital202000-01-012011-08-08

Narrower conditions

Nephrotic Syndrome (15)  ·  Nephrosis, Lipoid (5)  ·  Proteinuria (3)  ·  Glomerulonephritis (2)  ·  Glomerulonephritis, Membranous (2)  ·  Nephritis (2)  ·  Diabetic Nephropathies (1)  ·  Dyslipidemias (1)  ·  Edema (1)  ·  Glomerulonephritis, IGA (1)  ·  Glomerulosclerosis, Focal Segmental (1)  ·  IgA Vasculitis (1)  ·  Kidney Diseases (1)  ·  Renal Insufficiency, Chronic (1)

Broader conditions

Female Urogenital Diseases (17)  ·  Female Urogenital Diseases and Pregnancy Complications (17)  ·  Male Urogenital Diseases (17)  ·  Urogenital Diseases (17)  ·  Urologic Diseases (17)  ·  Kidney Diseases (16)  ·  Pathological Conditions, Signs and Symptoms (5)  ·  Signs and Symptoms (4)  ·  Immune System Diseases (3)  ·  Nephritis (3)  ·  Urination Disorders (3)  ·  Urological Manifestations (3)  ·  Autoimmune Diseases (2)  ·  Glomerulonephritis (2)

Interventions

Tacrolimus (5)  ·  Prednisolone (4)  ·  Mycophenolic Acid (3)  ·  Adrenocorticotropic Hormone (2)  ·  Acetazolamide (1)  ·  Atorvastatin (1)  ·  Furosemide (1)  ·  Prednisone (1)  ·  Steroids (1)  ·  Tablets (1)  ·  alfacalcidol (1)  ·  dapagliflozin (1)

Sponsors

Seoul National University Hospital (2)  ·  Ain Shams University (1)  ·  Arizona Kidney Disease and Hypertension Center (1)  ·  Astellas Pharma Korea, Inc. (1)  ·  Columbia University (1)  ·  Hospices Civils de Lyon (1)  ·  Imperial College Healthcare NHS Trust (1)  ·  Mallinckrodt (1)  ·  National Institute of Kidney Disease and Urology (NIKDU) (1)  ·  Oulu University Hospital (1)  ·  Shandong University (1)  ·  Shiraz University of Medical Sciences (1)  ·  Southeast Renal Research Institute (1)  ·  The Children's Hospital of Zhejiang University School of Medicine (1)  ·  The University of Hong Kong (1)

Countries

United States (4)  ·  South Korea (3)  ·  China (2)  ·  Bangladesh (1)  ·  Canada (1)  ·  Chile (1)  ·  Denmark (1)  ·  Egypt (1)  ·  Finland (1)  ·  France (1)  ·  Mexico (1)  ·  Turkey (Türkiye) (1)  ·  United Kingdom (1)

Top investigators

Gerald B Appel, MD (1)  ·  Hee Gyung Aurea Kang, M.D., Ph.D. (1)  ·  James A. Tumlin, MD (1)  ·  Jianhua Mao, MD (1)  ·  Justine Bacchetta, MD (1)  ·  Matti Nuutinen, M.D., Ph.D. (1)  ·  Megan Griffith, MBChBPhDFRCP (1)  ·  Mohammad Mahdi Sagheb, MD (1)  ·  Per Ivarsen (1)  ·  Saieef Zaman, MD (1)  ·  Sungchun Lee, M.D. (1)  ·  Sydney CW Tang, MD, PhD (1)

Results publications

PMID 35230699, PMID 39513526, PMID 12944064, PMID 14655180, PMID 16961774, PMID 17489822, PMID 17989649, PMID 21626222, PMID 22722778, PMID 23343906, PMID 23813218, PMID 24009220, PMID 24159603, PMID 31769845, PMID 31873802, PMID 34247632, PMID 34778952, PMID 3588043, PMID 36853224, PMID 40354041, PMID 41905593, PMID 7479966, PMID 7911091, PMID 9176846, PMID 9469489

NIH funding

2009 (1)